These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6093793)

  • 1. Inhibition of calmodulin-dependent cyclic nucleotide phosphodiesterase by flunarizine, a calcium-entry blocker.
    Kubo K; Matsuda Y; Kase H; Yamada K
    Biochem Biophys Res Commun; 1984 Oct; 124(2):315-21. PubMed ID: 6093793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a calcium-antagonist (flunarizine) on the in vitro growth of B16 mouse melanoma cells.
    Sezzi ML; Zupi G; De Luca G; Materazzi M; Bellelli L
    Anticancer Res; 1984; 4(4-5):229-34. PubMed ID: 6091526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calmodulin and Ca2+-dependent cyclic AMP phosphodiesterase activity in Trypanosoma cruzi.
    Téllez-Iñón MT; Ulloa RM; Torruella M; Torres HN
    Mol Biochem Parasitol; 1985 Nov; 17(2):143-53. PubMed ID: 2999589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase.
    Sharma RK
    Biochemistry; 1991 Jun; 30(24):5963-8. PubMed ID: 1646004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
    Sharma RK; Wang JH; Wu Z
    J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection with flunarizine against hypoxic-ischaemic damage of the rat cerebral cortex. A quantitative morphologic assessment.
    Van Reempts J; Borgers M; Van Dael L; Van Eyndhoven J; Van De Ven M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):76-88. PubMed ID: 6870389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of two calcium/calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography.
    Hansen RS; Beavo JA
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2788-92. PubMed ID: 6283544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Neurospora crassa cyclic AMP phosphodiesterase activated by calmodulin.
    Téllez-Iñón MT; Ulloa RM; Glikin GC; Torres HN
    Biochem J; 1985 Dec; 232(2):425-30. PubMed ID: 3004404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leucocytes as a model of Ca++ and Mg++-dependent cellular activation. Effect of calcium entry blockers.
    Di Perri T; Laghi Pasini F; Pasqui AL; Ceccatelli L; Orrico A; Capecchi PL
    Int J Tissue React; 1985; 7(4):291-301. PubMed ID: 3934096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of calmodulin-dependent functional protein, phosphodiesterase, in the lens.
    Yamamoto T; Iwata S
    Jpn J Ophthalmol; 1987; 31(4):570-81. PubMed ID: 2834593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a calcium-antagonist (flunarizine) on cancer cell movement and phagocytosis.
    Sezzi ML; De Luca G; Materazzi M; Bellelli L
    Anticancer Res; 1985; 5(3):265-71. PubMed ID: 4015040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.
    Nakanishi S; Osawa K; Saito Y; Kawamoto I; Kuroda K; Kase H
    J Antibiot (Tokyo); 1992 Mar; 45(3):341-7. PubMed ID: 1374373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin-stimulated cyclic nucleotide phosphodiesterase from Neurospora crassa.
    Ortega Perez R; Van Tuinen D; Marmé D; Turian G
    Biochim Biophys Acta; 1983 Jul; 758(1):84-7. PubMed ID: 6305427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insensitivity of calcium-dependent endothelial stimulation in rat isolated aorta to the calcium entry blocker, flunarizine.
    Miller RC; Schoeffter P; Stoclet JC
    Br J Pharmacol; 1985 Jun; 85(2):481-7. PubMed ID: 2992665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunarizine, a calcium influx blocker, inhibits TRH-but not potassium-stimulated prolactin secretion.
    Merritt JE; Tomlinson S; Brown BL
    Acta Endocrinol (Copenh); 1984 Sep; 107(1):31-5. PubMed ID: 6435368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
    Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
    Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of cinnarizine and related compounds on [3H]nitrendipine binding in the brain, heart and ileum.
    Ehlert FJ; Yamamura HI
    Life Sci; 1984 Jun; 34(24):2347-55. PubMed ID: 6328164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leukocyte as a model of Ca++ and Mg++-dependent cellular activation. Effect of flunarizine.
    Di Perri T; Laghi Pasini F; Pasqui AL; Ceccatelli L; Capecchi PL; Orrico A
    Microcirc Endothelium Lymphatics; 1984 Aug; 1(4):415-29. PubMed ID: 6100790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.